期刊文献+

乙型肝炎病毒外膜大蛋白与HBV DNA、ALT的关系及其临床意义 被引量:2

Investigation of the clinical value of hepatitis B virus large envelope protein and its relationship with HBV DNA and ALT
下载PDF
导出
摘要 目的检测不同模式乙肝患者血清中乙肝病毒外膜大蛋白(HBV-LP)、HBV DNA以及转氨酶情况,比较HBV-LP的检出与HBV DNA及转氨酶的关系。方法采用酶联免疫吸附法检测199例HBV患者血清HBV-LP,荧光定量PCR法检测患者HBV DNA,全自动生化分析仪检测转氨酶。结果相同乙肝模式患者血清HBV-LP与HBV DNA检出率差异无统计学意义。HBeAg阳性患者血清中,HBV-LP与HBV DNA阳性率均明显高于HBeAg阴性患者(92.45%与42.04%,P<0.05;90.57%与38.85%,P<0.05)。HBV-LP阳性患者的转氨酶水平明显高于HBV-LP阴性患者。结论 HBV-LP与HBV DNA有较高的符合率,是反映乙肝患者体内病毒复制情况的可靠指标。而且,HBV-LP阳性患者转氨酶较阴性患者高,表明HBV-LP同时也反映了乙肝病情的活动情况。 Objective To explore the clinical significance of hepatitis B virus large protein(HBV-LP) in the diagnosis of viral replication. Methods Serum samples were collected from 199 patients with HBV infection. HBV-LP and HBV markers were exam- ined using enzyme linked immunosorbent assay(ELISA). HBV DNA was quantitatively detected by real-time polymerase chain reaction. The level of alanine aminotransferase(ALT) was obtained by an automated biochemistry analyzer. Results No significant difference of detection rates was found between HBV DNA and HBV-LP in patients with the same HBV markers. The positive rates of HBV-LP and HBV DNA in patients with HBeAg were higher than those without HBeAg (92.45% vs 42.04% ,P〈0.05; 90.57% vs 38.85M ,P〈0. 05). The average level of ALT in HBV-LP-positive patients was higher than that of HBV-LP-negative ones. Conclusion There could be a perfect correlation between the positive rate of HBV-LP and HBV DNA,and HBV-LP could be a reliable serological marker that can reflect the replication of HBV as well as liver function.
作者 牛文强 陈杰
出处 《国际检验医学杂志》 CAS 2011年第10期1045-1046,共2页 International Journal of Laboratory Medicine
关键词 肝炎表面抗原 乙型 丙氨酸转氨酶 乙肝病毒DNA hepatitis B surface antigens alanine aminotransferase hepatitis B virus DNA
  • 相关文献

参考文献9

二级参考文献74

共引文献1060

同被引文献40

  • 1QiangDeng Yu-YingKong You-HuaXie YuanWang.Expression and purification of the complete PreS region of hepatitis B Virus[J].World Journal of Gastroenterology,2005,11(20):3060-3064. 被引量:8
  • 2KIM BK, HAN KH, AHN SH. Hepatitis B virus serology to predict antiviral response in chronic hepatitis B [ J ] . Digestion, 2011, 84 : 29 - 34.
  • 3COULION S, HEINDRYCX, F, GEERTS A, et al. Angiogenesis in chronic liver disease and its complications [J] . Liver Int, 2011, 31(2): 146-162.
  • 4VANHEULE E, GEERTS AM, VAN HUYSSE J, et al. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice mod- els: relationship between fibrosis and angiogenesis [J] . Int J Exp Pathol, 2008, 89 (6): 419-432.
  • 5VON MARSCHALL Z, CRAMER T, HOCKER M, et al. Dual mocha- nism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma [ J ] . Gut, 2001, 48 ( 1 ) : 87 - 96.
  • 6DRAFF A, WEINDDK OCHDS A, et al. Vascular endothelia growth factor in the sera and effusions of patients with malignant and non-ma- lignant disease [J] . Cancer, 1999, 85:178 -187.
  • 7郭燕萍,杨广英,王建君,等.肝组织中转化生长因子-B1、血管内皮生长因子及微血管密度的表达在肝纤维化中的作用及意义[J].中国实用医刊,2008,35(27):10-11.
  • 8JINNO K, WANG W, ELLIS L, et al. NF-Kappa B regulates VEGF gene expression in human pancreatic cancers [ J ]. Proc Annu Meet Am Assoc Res, 1996, 37 (4) : 525 -530.
  • 9GADELHAK NA, GADELHAK SA, EL-MORSI DA, et al. Prognostic significance of three hepatitis markers ( p53 antibod- ies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma [ J] . Hepatogastmenterolo- gy, 2009, 56 (94-95): 1417-1424.
  • 10KASED AO, HANBALI A, COTANT M, et al. Vascular endothelial growth factor in the management of hepatocellular carcinoma: a review of literature [J] .Cancer, 2009, 115 (21): 4895-4906.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部